Roderick N. Allen serves as Executive at RTI Biologics, Inc., where they oversee executive responsibilities. Since joining the company, Roderick N. Allen has executed 1 insider transactions totaling $3.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 30, 2008 involved purchasing 1,218 shares valued at $3.4K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Oct 30, 2008 | RTIX | $3.4K | Purchase | 1,218 | $2.76 | Discretionary |
Roderick N. Allen currently holds 4,218 shares of RTI Biologics, Inc. (RTIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Roderick N. Allen has been a net buyer of RTIX stock. They have purchased $3.4K and sold $0 worth of shares.
Roderick N. Allen's most recent insider trade was on Oct 30, 2008, when they purchased 1,218 shares at $2.76 per share.
Get notified when new Form 4 filings are submitted